Does Rallies show Form 4 insider transactions for SEM?

Yes. Rallies tracks SEM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SEM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SEM. It does not provide personalized investment advice.

SEM (SELECT MEDICAL HOLDINGS CORP) Stock Analysis - Insider Trades

SELECT MEDICAL HOLDINGS CORP (SEM) is a publicly traded Healthcare sector company. As of May 21, 2026, SEM trades at $16.52 with a market cap of $2.04B and a P/E ratio of 14.28. SEM moved +0.27% today. Year to date, SEM is +9.04%; over the trailing twelve months it is +9.26%. Its 52-week range spans $11.65 to $40.98. Analyst consensus is neutral with an average price target of $16.50. Rallies surfaces SEM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SEM stock inside the company?

Recent SEM insider activity includes Khanuja Parvinderjit S. bought 21.00K, CHERNOW DAVID S sold 225.00K, Breighner Robert G. JR sold 4.99K, ORTENZIO ROBERT A sold 3.80M, and TAVENNER MARILYN B sold 32.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SEM Key Metrics

Key financial metrics for SEM
Metric	Value
Price	$16.52
Market Cap	$2.04B
P/E Ratio	14.28
EPS	$1.16
Dividend Yield	0.06%
52-Week High	$40.98
52-Week Low	$11.65
Volume	0
Avg Volume	0
Revenue (TTM)	$5.45B
Net Income	$214.53M
Gross Margin	0.00%

Recent SEM Insider Trades

Khanuja Parvinderjit S. bought 21.00K (~$315.42K) on May 5, 2025.
CHERNOW DAVID S sold 225.00K (~$4.05M) on Apr 28, 2025.
Breighner Robert G. JR sold 4.99K (~$99.53K) on Dec 4, 2024.
ORTENZIO ROBERT A sold 3.80M (~$74.38M) on Nov 26, 2024.
TAVENNER MARILYN B sold 32.00K (~$674.88K) on Nov 26, 2024.

Latest SEM News

Select Medical Agrees $16.50 Share Merger, Q1 Revenue Climbs 5% to $1.42B — Apr 30, 2026
Select Medical HSR Antitrust Waiting Period Expires Ahead of Mid-2026 Merger — Apr 28, 2026
Select Medical Faces Probe Over $16.50 Cash-Per-Share Buyout Deal — Apr 14, 2026
Shareholder Suit Targets Select Medical $16.50 Cash Deal With Executive-Led Consortium — Mar 10, 2026
Select Medical Sale Faces Investigation Over $16.50 Executive-Led Consortium Deal — Mar 6, 2026

SEM Analyst Consensus

4 analysts cover SEM: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $16.50.

Common questions about SEM

Who is trading SEM stock inside the company?: Recent SEM insider activity includes Khanuja Parvinderjit S. bought 21.00K, CHERNOW DAVID S sold 225.00K, Breighner Robert G. JR sold 4.99K, ORTENZIO ROBERT A sold 3.80M, and TAVENNER MARILYN B sold 32.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SEM?: Yes. Rallies tracks SEM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SEM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SEM. It does not provide personalized investment advice.